166 related articles for article (PubMed ID: 10585160)
1. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
Brickell KL; Nicholson LF; Waldvogel HJ; Faull RL
J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
[TBL] [Abstract][Full Text] [Related]
2. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease.
Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016
[TBL] [Abstract][Full Text] [Related]
3. γ-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions.
Rekik L; Daguin-Nerrière V; Petit JY; Brachet P
J Neurosci Res; 2011 Apr; 89(4):524-35. PubMed ID: 21290407
[TBL] [Abstract][Full Text] [Related]
4. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
5. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
6. GABAA receptor subtype changes in the substantia nigra of the rat following quinolinate lesions in the striatum: a correlative in situ hybridization and immunohistochemical study.
Nicholson LF; Waldvogel HJ; Faull RL
Neuroscience; 1996 Sep; 74(1):89-98. PubMed ID: 8843079
[TBL] [Abstract][Full Text] [Related]
7. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
[TBL] [Abstract][Full Text] [Related]
8. Synaptic localization of GABA(A) receptor subunits in the substantia nigra of the rat: effects of quinolinic acid lesions of the striatum.
Fujiyama F; Stephenson FA; Bolam JP
Eur J Neurosci; 2002 Jun; 15(12):1961-75. PubMed ID: 12099902
[TBL] [Abstract][Full Text] [Related]
9. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
[TBL] [Abstract][Full Text] [Related]
10. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
Beal MF; Ferrante RJ; Swartz KJ; Kowall NW
J Neurosci; 1991 Jun; 11(6):1649-59. PubMed ID: 1710657
[TBL] [Abstract][Full Text] [Related]
11. Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesion in rats.
Block F; Schwarz M
Neuroreport; 1994 Nov; 5(17):2237-40. PubMed ID: 7881035
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
13. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
14. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
Levivier M; Gash DM; Przedborski S
Neuroscience; 1995 Nov; 69(1):43-50. PubMed ID: 8637631
[TBL] [Abstract][Full Text] [Related]
15. Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.
Gramsbergen JB; van der Sluijs-Gelling AJ
Exp Neurol; 1993 Jun; 121(2):261-9. PubMed ID: 8339777
[TBL] [Abstract][Full Text] [Related]
16. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy).
Scherfler C; Puschban Z; Ghorayeb I; Goebel GP; Tison F; Jellinger K; Poewe W; Wenning GK
Neuroscience; 2000; 99(1):43-54. PubMed ID: 10924951
[TBL] [Abstract][Full Text] [Related]
17. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
[TBL] [Abstract][Full Text] [Related]
18. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
Bordelon YM; Chesselet MF
Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
[TBL] [Abstract][Full Text] [Related]
19. Basal ganglia lesions in the rat: effects on quinolinic acid metabolism.
Schwarcz R; Okuno E; White RJ
Brain Res; 1989 Jun; 490(1):103-9. PubMed ID: 2527078
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
Olds ME; Jacques DB; Kopyov O
Synapse; 2005 Jan; 55(1):26-36. PubMed ID: 15499610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
